{
  "id": 17934439,
  "title": "Chinese drug iza-bren doubles lung cancer survival window in phase 3 trial",
  "url": "https://urgent.news/2026/11/03/chinese-drug-iza-bren-doubles-lung-cancer-survival-window-in-phase-3-17934439",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-03T08:00:09.000Z",
  "source": {
    "name": "South China Morning Post",
    "slug": "south-china-morning-post",
    "url": "https://www.scmp.com/news/china/science/article/3373061/chinese-drug-iza-bren-doubles-lung-cancer-survival-window-phase-3-trial"
  },
  "original_language": "en",
  "account": null,
  "summary": "An anticancer drug developed by Sichuan Biokin Pharmaceutical took centre stage in a late-breaking oral presentation at the European Society for Medical Oncology (ESMO) Congress in Madrid last week. Researchers said the drug, iza-bren, showed a significant advantage over platinum-based chemotherapy in a phase 3 randomised, double-blind clinical trial conducted at 73 hospitals in China and…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}